250 related articles for article (PubMed ID: 21044435)
1. Efficacy of methotrexate in comparison to biologics in rheumatoid arthritis.
Rau R
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S58-64. PubMed ID: 21044435
[TBL] [Abstract][Full Text] [Related]
2. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.
Jansen JP; Buckley F; Dejonckheere F; Ogale S
Health Qual Life Outcomes; 2014 Jul; 12():102. PubMed ID: 24988902
[TBL] [Abstract][Full Text] [Related]
4. Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis.
Guyot P; Taylor P; Christensen R; Pericleous L; Poncet C; Lebmeier M; Drost P; Bergman G
Arthritis Res Ther; 2011; 13(6):R204. PubMed ID: 22151924
[TBL] [Abstract][Full Text] [Related]
5. Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis.
Buckley F; Finckh A; Huizinga TW; Dejonckheere F; Jansen JP
J Manag Care Spec Pharm; 2015 May; 21(5):409-23. PubMed ID: 25943002
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis.
Alfonso-Cristancho R; Armstrong N; Arjunji R; Riemsma R; Worthy G; Ganguly R; Kleijnen J
Clin Rheumatol; 2017 Jan; 36(1):25-34. PubMed ID: 27726046
[TBL] [Abstract][Full Text] [Related]
7. Examining the efficacy of biologic therapy: are there real differences?
Fleischmann RM
J Rheumatol Suppl; 2002 Sep; 65():27-32. PubMed ID: 12236619
[TBL] [Abstract][Full Text] [Related]
8. Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom.
Guyot P; Taylor PC; Christensen R; Pericleous L; Drost P; Eijgelshoven I; Bergman G; Lebmeier M
J Rheumatol; 2012 Jun; 39(6):1198-206. PubMed ID: 22505698
[TBL] [Abstract][Full Text] [Related]
9. The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis.
Ruderman EM
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S29-32. PubMed ID: 24219038
[TBL] [Abstract][Full Text] [Related]
10. A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach.
Schmitz S; Adams R; Walsh CD; Barry M; FitzGerald O
Ann Rheum Dis; 2012 Feb; 71(2):225-30. PubMed ID: 21960560
[TBL] [Abstract][Full Text] [Related]
11. The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrollment: data from a systematic review and meta-analysis.
Favalli EG; Pregnolato F; Biggioggero M; Meroni PL
Semin Arthritis Rheum; 2014 Jun; 43(6):730-7. PubMed ID: 24332807
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis.
Nam JL; Ramiro S; Gaujoux-Viala C; Takase K; Leon-Garcia M; Emery P; Gossec L; Landewe R; Smolen JS; Buch MH
Ann Rheum Dis; 2014 Mar; 73(3):516-28. PubMed ID: 24399231
[TBL] [Abstract][Full Text] [Related]
13. Is it possible to withdraw biologics from therapy in rheumatoid arthritis?
Tanaka Y; Hirata S
Clin Ther; 2013 Dec; 35(12):2028-35. PubMed ID: 24290736
[TBL] [Abstract][Full Text] [Related]
14. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
Sesin CA; Bingham CO
Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
16. Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate.
Kobayakawa T; Kojima T; Takahashi N; Hayashi M; Yabe Y; Kaneko A; Shioura T; Saito K; Hirano Y; Kanayama Y; Miyake H; Asai N; Funahashi K; Hirabara S; Hanabayashi M; Asai S; Ishiguro N
Mod Rheumatol; 2015 Mar; 25(2):251-6. PubMed ID: 25211402
[TBL] [Abstract][Full Text] [Related]
17. Are All Biologics the Same? Optimal Treatment Strategies for Patients With Early Rheumatoid Arthritis: Systematic Review and Indirect Pairwise Meta-Analysis.
Albert DA
J Clin Rheumatol; 2015 Dec; 21(8):398-404. PubMed ID: 26226612
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of clinical and radiological efficacy of biologics in rheumatoid arthritis patients naive or inadequately responsive to methotrexate.
Pierreisnard A; Issa N; Barnetche T; Richez C; Schaeverbeke T
Joint Bone Spine; 2013 Jul; 80(4):386-92. PubMed ID: 23141718
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of biological agents in methotrexate-refractory rheumatoid arthritis patients: a Bayesian mixed treatment comparison.
Choi M; Hyun MK; Choi S; Tchoe HJ; Lee SY; Son KM; Kim MJ; Jung YO; Kim HA
Korean J Intern Med; 2017 May; 32(3):536-547. PubMed ID: 27253239
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Symmons DP; Watson KD; Silman AJ;
Arthritis Rheum; 2006 Jun; 54(6):1786-94. PubMed ID: 16736520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
